|
LOC641298 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.15749999998849E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.14079999996775E-06 |
| Normal-vs-Stage2 |
3.820500E-03 |
| Normal-vs-Stage3 |
6.496000E-03 |
| Normal-vs-Stage4 |
9.145700E-02 |
| Stage1-vs-Stage2 |
6.837000E-01 |
| Stage1-vs-Stage3 |
2.766800E-01 |
| Stage1-vs-Stage4 |
9.225800E-02 |
| Stage2-vs-Stage3 |
2.483400E-01 |
| Stage2-vs-Stage4 |
9.889600E-02 |
| Stage3-vs-Stage4 |
4.722600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.78760000000023E-06 |
| Normal-vs-AfricanAmerican |
3.743600E-02 |
| Normal-vs-Asian |
4.375800E-03 |
| Caucasian-vs-AfricanAmerican |
8.234400E-01 |
| Caucasian-vs-Asian |
5.434600E-01 |
| AfricanAmerican-vs-Asian |
5.038400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.11139999999732E-05 |
| Normal-vs-Female |
4.04240000000389E-05 |
| Male-vs-Female |
5.369600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.507200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.47050000024407E-07 |
| Normal-vs-Age(61-80Yrs) |
1.279450E-03 |
| Normal-vs-Age(81-100Yrs) |
2.677800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.285400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.444200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.757000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.630400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.348600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.200200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.145650E-02 |
| Normal-vs-Grade 2 |
1.61060000003488E-06 |
| Normal-vs-Grade 3 |
3.967800E-04 |
| Normal-vs-Grade 4 |
3.369600E-01 |
| Grade 1-vs-Grade 2 |
2.686600E-01 |
| Grade 1-vs-Grade 3 |
1.012990E-01 |
| Grade 1-vs-Grade 4 |
6.142600E-03 |
| Grade 2-vs-Grade 3 |
2.395600E-01 |
| Grade 2-vs-Grade 4 |
3.735600E-03 |
| Grade 3-vs-Grade 4 |
5.213600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.8511999962162E-08 |
| Normal-vs-ccB subtype |
7.021700E-03 |
| ccA subtype-vs-ccB subtype |
9.797600E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.77099999998376E-06 |
| Normal-vs-N1 |
5.811600E-01 |
| N0-vs-N1 |
2.700200E-01 |
|
|
